Friday, 23 Mar 2018

Biologic/Novel Rx

Datesort ascending Type Title Save
12 Apr 2017 Social When BIOSIMILARS become available will PATIENTS use/accept them or switch to them? Survey for Patients, vote now>>
12 Apr 2017 Social PATIENTS - BIOSIMILAR Questions- a RheumNow survey on how they will affect you. Make your vote count!
12 Apr 2017 Social Looking for PATIENT Views on BIOSIMILAR BIOLOGIC Drugs - They're new, how will they affect you. Patients vote at>>
08 Apr 2017 Social RT @HealioRheum: Dr. William Rigby (@GeiselMed): The fact is, these JAKs work
07 Apr 2017 Social Dr. Laura Cappelli - Talk on checkpoint inhibitors of PD-1 (nivolumab, pembrolizumab) and CTLA4 (impilimumab) commonly used in chemotherapy
06 Apr 2017 Social Dr Jon Kay - a biomarker is a measured indicator of biologic/pathogenic processes or drug responses to a therapeutic intervention #CCFsummit
04 Apr 2017 Social FDA grants "breakthrough status" (expedited review) for Rituximab in Pemphigus Vulgaris based on recent Lancet study
04 Apr 2017 News Abatacept Use During Surgery
04 Apr 2017 Social FDAs Oncology Advisory Committee votes 11-0 approve subcut rituximab for lymphoma & CLL. Given in minutes not hours
13 Mar 2017 Social Review of severe alopecia areata 90pts Rx w/ Xeljanz: 20% nearly total regrowth, 58% >50% regrowth,77% some regrowth
09 Mar 2017 News European Biologic Manufacturers Issue Warnings About Biosimilar Switching
07 Mar 2017 Social Placebo outperforms Anakinra (22% vs 8%) in 50 patients with chronic Fatigue Syndrome. IL-1 inhibition fails in CFS
28 Feb 2017 Social Just like Oral Strategy Study (MTX+Tofa > Tofa), DREAM registry shows TNFi + MTX > TNFi.
27 Feb 2017 News High Level Rheumatoid Responses to the GM-CSF inhibitor Mavrilimumab
23 Feb 2017 News Sirukumab Effective in Rheumatoid Arthritis
20 Feb 2017 News Abatacept Efficacy Giant Cell Arteritis
20 Feb 2017 Social Dr Mahadevan #RWCS17 ustekinumab has been approved for Crohns disease
17 Feb 2017 Social RT @DrRachelTate: No changes in safety, efficacy, or ab production in IFX vs inflectra. Eric Ruderman, MD & Arthur Kavanaugh, MD #rwcs2017…
17 Feb 2017 News Biosimilar Reports – February 2017
17 Feb 2017 Social Dr Kevin Winthrop at #RWCS2017 reviews DMARD/Biologic effects on vaccine responses. Most effected by RTX, least by…